Klemm M, Cheng C, Cassell G, Shuman S, Segall A M
Department of Biology and Molecular Biology Institute, San Diego State University, San Diego, CA, 92182, USA.
J Mol Biol. 2000 Jun 23;299(5):1203-16. doi: 10.1006/jmbi.2000.3829.
The study of biochemical pathways requires the isolation and characterization of each and every intermediate in the pathway. For the site-specific recombination reactions catalyzed by the bacteriophage lambda tyrosine recombinase integrase (Int), this has been difficult because of the high level of efficiency of the reaction, the highly reversible nature of certain reaction steps, and the lack of requirements for high-energy cofactors or metals. By screening synthetic peptide combinatorial libraries, we have identified two related hexapeptides, KWWCRW and KWWWRW, that block the strand-cleavage activity of Int but not the assembly of higher-order intermediates. Although the peptides bind DNA, their inhibitory activity appears to be more specifically targeted to the Int-substrate complex, insofar as inhibition is resistant to high levels of non-specific competitor DNA and the peptides have higher levels of affinity for the Int-DNA substrate complex than for DNA alone. The peptides inhibit the four pathways of Int-mediated recombination with different potencies, suggesting that the interactions of the Int enzyme with its DNA substrates differs among pathways. The KWWCRW and KWWWRW peptides also inhibit vaccinia virus topoisomerase, a type IB enzyme, which is mechanistically and structurally related to Int. The peptides differentially affect the forward and reverse DNA transesterification steps of the vaccinia topoisomerase. They block formation of the covalent vaccinia topoisomerase-DNA intermediate, but have no apparent effect on DNA religation by preformed covalent complexes. The peptides also inhibit Escherichia coli topoisomerase I, a type IA enzyme. Finally, the peptides inhibit the bacteriophage T4 type II topoisomerase and several restriction enzymes with 2000-fold lower potency than they inhibit integrase in the bent-L pathway.
对生化途径的研究需要分离和鉴定该途径中的每一个中间体。对于由噬菌体λ酪氨酸重组酶整合酶(Int)催化的位点特异性重组反应而言,由于反应效率高、某些反应步骤具有高度可逆性,且不需要高能辅因子或金属,因此很难做到这一点。通过筛选合成肽组合文库,我们鉴定出了两种相关的六肽,即KWWCRW和KWWWRW,它们可阻断Int的链切割活性,但不影响高阶中间体的组装。尽管这些肽与DNA结合,但其抑制活性似乎更特异性地靶向Int-底物复合物,因为抑制作用对高水平的非特异性竞争DNA具有抗性,并且这些肽对Int-DNA底物复合物的亲和力高于对单独DNA的亲和力。这些肽以不同的效力抑制Int介导的四种重组途径,这表明Int酶与其DNA底物之间的相互作用在不同途径中有所不同。KWWCRW和KWWWRW肽还可抑制痘苗病毒拓扑异构酶,这是一种IB型酶,在机制和结构上与Int相关。这些肽对痘苗拓扑异构酶的正向和反向DNA转酯步骤有不同影响。它们可阻断共价痘苗拓扑异构酶-DNA中间体的形成,但对预先形成的共价复合物进行的DNA重新连接没有明显影响。这些肽还可抑制大肠杆菌拓扑异构酶I,这是一种IA型酶。最后,这些肽抑制噬菌体T4 II型拓扑异构酶和几种限制酶,其效力比它们在弯曲-L途径中抑制整合酶的效力低2000倍。